| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |